Top Pharmaceuticals companies in the world by Net Income Margin

This ranking features the top 2,357 Pharmaceuticals companies in the world ranked by Net Income Margin, averaging a Net Income Margin of -854,943.55%, for January 15, 2025.

Global

Pharmaceuticals

#	Name	Net Income Margin	Reported Date	Stock Price	Change	Country
1	Inhibrx Biosciences, Inc. 1 INBX	94,684.72%	Sept. 30, 2024	USD 12.74	-6.60%	United States
2	Linc AB 2 LINC.ST	16,971.48%	Dec. 31, 2023	USD 8.02	0.46%	Sweden
3	Roivant Sciences Ltd. 3 ROIV	3,484.86%	March 31, 2024	USD 10.94	1.86%	United Kingdom
4	Eledon Pharmaceuticals, Inc. 4 ELDN	2,168.39%	Sept. 30, 2024	USD 3.71	-4.63%	United States
5	Agios Pharmaceuticals, Inc. 5 AGIO	2,051.38%	Sept. 30, 2024	USD 33.32	-2.86%	United States
6	Oramed Pharmaceuticals Inc. 6 ORMP	1,551.34%	March 31, 2024	USD 2.36	NA	United States
7	Immuneering Corporation 7 IMRX	1,085.06%	Sept. 30, 2023	USD 1.95	-2.99%	United States
8	MPH Health Care AG 8 93M1.DE	408.26%	Dec. 31, 2023	USD 24.32	-0.24%	Germany
9	RedHill Biopharma Ltd. 9 RDHL	367.19%	Dec. 31, 2023	USD 5.51	-1.08%	Israel
10	Oncimmune Holdings plc 10 ONC.L	356.25%	Aug. 31, 2023	USD 0.16	-0.68%	United Kingdom
11	Pharmena S.A. 11 PHR.WA	294.21%	Dec. 31, 2023	USD 1.01	1.23%	Poland
12	Alembic Limited 12 ALEMBICLTD.NS	170.57%	March 31, 2024	USD 1.41	4.27%	India
13	TaiGen Biopharmaceuticals Holdings Limited 13 4157.TWO	111.04%	Dec. 31, 2023	USD 0.32	0.12%	Taiwan
14	Formycon AG 14 FYB.DE	97.55%	Dec. 31, 2023	USD 60.50	-1.24%	Germany
15	Cipher Pharmaceuticals Inc. 15 CPH.TO	96.32%	Dec. 31, 2023	USD 9.40	-4.39%	Canada
16	Galapagos NV 16 GLPG.AS	88.31%	Dec. 31, 2023	USD 24.20	-0.41%	Belgium
17	Alar Pharmaceuticals Inc. 17 6785.TWO	81.53%	Dec. 31, 2023	USD 4.09	5.18%
18	Uniphos Enterprises Limited 18 UNIENTER.NS	76.24%	March 31, 2024	USD 1.74	3.76%	India
19	Cathay Chemical Works Inc. 19 1713.TW	73.55%	Dec. 31, 2023	USD 1.38	0.78%	Taiwan
20	Edwards Lifesciences Corporation 20 EW	70.82%	Sept. 30, 2024	USD 71.04	-0.07%	United States
21	L&C Bio Co., Ltd 21 290650.KQ	70.22%	Dec. 31, 2023	USD 16.30	-3.69%	South Korea
22	Imeik Technology Development Co.,Ltd. 22 300896.SZ	64.77%	Dec. 31, 2023	USD 23.99	3.90%	China
23	Ajinomoto (Malaysia) Bhd 23 2658.KL	63.07%	March 31, 2024	USD 3.29	-0.45%	Malaysia
24	Bioventix PLC 24 BVXP.L	59.51%	June 30, 2024	USD 39.06	2.49%	United Kingdom
25	Kangji Medical Holdings Limited 25 9997.HK	54.43%	Dec. 31, 2023	USD 0.77	2.02%	China
26	Santhera Pharmaceuticals Holding AG 26 SANN.SW	52.97%	Dec. 31, 2023	USD 14.50	8.00%	Switzerland
27	Protagonist Therapeutics, Inc. 27 PTGX	52.76%	Sept. 30, 2024	USD 36.67	-1.26%	United States
28	Pro Medicus Limited 28 PME.AX	51.27%	June 30, 2024	USD 157.25	0.24%	Australia
29	Royalty Pharma plc 29 RPRX	50.54%	Sept. 30, 2024	USD 30.03	0.13%	United States
30	SIGA Technologies, Inc. 30 SIGA	49.33%	Sept. 30, 2024	USD 6.33	4.46%	United States
31	Yantai Zhenghai Biotechnology Co., Ltd. 31 300653.SZ	46.16%	Dec. 31, 2023	USD 2.82	2.48%	China
32	Shanghai Yizhong Pharmaceutical Co., Ltd. 32 688091.SS	44.84%	Dec. 31, 2023	USD 4.94	3.02%	China
33	Akeso, Inc. 33 9926.HK	44.81%	Dec. 31, 2023	USD 7.28	2.32%	China
34	Beijing Succeeder Technology Inc. 34 688338.SS	42.44%	Dec. 31, 2023	USD 3.27	2.18%	China
35	Jilin Aodong Pharmaceutical Group Co., Ltd. 35 000623.SZ	42.33%	Dec. 31, 2023	USD 2.25	3.72%	China
36	EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. 36 ECILC.IS	42.28%	Dec. 31, 2023	USD 1.24	-0.32%	Turkey
37	Shenzhen New Industries Biomedical Engineering Co., Ltd. 37 300832.SZ	42.08%	Dec. 31, 2023	USD 8.51	2.10%	China
38	Shanghai MicroPort Endovascular MedTech Co., Ltd. 38 688016.SS	41.90%	Dec. 31, 2023	USD 15.35	4.46%	China
39	Bonesupport Holding AB (publ) 39 BONEX.ST	41.45%	Dec. 31, 2023	USD 32.97	-0.61%	Sweden
40	Halozyme Therapeutics, Inc. 40 HALO	41.43%	Sept. 30, 2024	USD 53.83	-0.57%	United States
41	Giant Biogene Holding Co., Ltd. 41 2367.HK	41.19%	Dec. 31, 2023	USD 6.64	6.03%	China
42	Beijing SL Pharmaceutical Co., Ltd. 42 002038.SZ	40.92%	Dec. 31, 2023	USD 1.04	1.87%	China
43	Pak Fah Yeow International Limited 43 0239.HK	40.51%	Dec. 31, 2023	USD 0.31	0.39%	Hong Kong
44	Clinuvel Pharmaceuticals Limited 44 CUV.AX	40.41%	June 30, 2024	USD 7.32	6.16%	Australia
45	United Therapeutics Corporation 45 UTHR	40.31%	Sept. 30, 2024	USD 364.70	0.50%	United States
46	InMode Ltd. 46 INMD	40.22%	Dec. 31, 2023	USD 16.07	0.63%	Israel
47	G&E Herbal Biotechnology Co., Ltd. 47 4911.TWO	39.90%	Dec. 31, 2023	USD 1.63	0.49%
48	Jenkem Technology Co., Ltd. 48 688356.SS	39.62%	Dec. 31, 2023	USD 7.16	2.79%	China
49	Genovis AB (publ.) 49 GENO.ST	38.87%	Dec. 31, 2023	USD 2.09	-2.04%	Sweden
50	Andon Health Co., Ltd. 50 002432.SZ	38.74%	Dec. 31, 2023	USD 5.45	2.10%	China

1 2 3 4 … 48

Frequently Asked Questions

Which Pharmaceuticals company has the highest Net Income Margin ?

The Pharmaceuticals company with the highest Net Income Margin is Inhibrx Biosciences, Inc. (NasdaqGS: INBX) at 94,684.72%.
Which Pharmaceuticals company has the lowest Net Income Margin ?

The Pharmaceuticals company with the lowest Net Income Margin is Inhibikase Therapeutics, Inc. (NasdaqCM: IKT) at -1,956,524,900.00%.

What are the top 10 Pharmaceuticals companies by Net Income Margin ?

The top 10 Pharmaceuticals companies the Global by Net Income Margin are Inhibrx Biosciences, Inc., Linc AB, Roivant Sciences Ltd., Eledon Pharmaceuticals, Inc., Agios Pharmaceuticals, Inc., Oramed Pharmaceuticals Inc., Immuneering Corporation, MPH Health Care AG, RedHill Biopharma Ltd. and Oncimmune Holdings plc.
What are the bottom 10 Pharmaceuticals companies by Net Income Margin ?

The bottom 10 Pharmaceuticals companies by Net Income Margin are Inhibikase Therapeutics, Inc., Molecure S.A., ZyVersa Therapeutics, Inc., Inovio Pharmaceuticals, Inc., BrightPath Biotherapeutics Co., Ltd., Genomtec S.A., Summit Therapeutics Inc., Allogene Therapeutics, Inc., Forte Biosciences, Inc. and OncoZenge AB (publ).